Manage Pain, Not Regulations
Six weeks. That’s how long I laid in agony. I waited for six weeks as my doctor
tried one thing after another, before finally prescribing adequate pain medication for my
previously diagnosed juvenile arthritis. He was following protocol, of course, but lying in
bed for six weeks as I was denied the pain relief I desperately craved, makes protocol a
poor excuse for waiting. Had he prescribed them sooner, I would not have spent those
many weeks in pain. However, that was not the “appropriate” way to handle the situation.
Regulations mandated that he prescribe exercise and the weakest type of pain
medications before slowly progressing to stronger ones. Because of this, I spent two
weeks in an intensive exercise program, followed by four weeks of taking weak pain
relievers such as acetaminophen, a nonsteroidal anti-inflammatory drug (NSAID)
commonly found in Tylenol and Midol, and naproxene, a different NSAID found in
Aleve. Then, my doctor prescribed diclofenac, another NSAID specified towards
arthritis. It was not until these methods had failed did I progress up the medicinal totem
pole. Finally, I was prescribed prednisone, a corticosteroid hormone, which was at least
more successful than the other pain medications. This, however, took weeks to achieve.
This is only one example of the many people who anxiously await adequate pain relief,
while doctors prescribe one useless thing after another, under the pretense of protocol.
Protocol is one of the main issues discussed in the larger debate surrounding pain
management. At the root of the problem is the inconsistency among doctors. Some
doctors adhere to protocol like it is stitched to their sides, while others merely consider it
a guideline. Knowing when it’s appropriate to follow protocol and when it is better to
think out of the box would contribute to the establishment of consistent care.
Although consistency is important, the bigger issue at hand concerns the
regulations that determine protocol, though this is linked to consistency as well. Because
there has been both the problem of doctors who over-prescribe pain medications and
those who under-prescribe them, regulations appear to be necessary. While everyone can
agree that they are necessary, it is difficult to come to a conclusion as to how far they
should go. There will always be those who believe they do not go far enough and those
who believe they go too far. Therefore the current question remains whether regulations
are too strict or not strict enough in regard to prescription pain medications, especially
Patients, as well as some doctors, believe that the regulations go too far, and that
patient care is suffering because of it. They think a patient’s pain should be prioritized
above following regulations, and protocols that sometimes make acquiring adequate
medication and relief more challenging. It is their belief that doctors are not taking their
patients seriously enough, and also that the availability of stronger pain medicine should
be increased rather than decreased due to the concerns of doctors and government
On the other hand, government officials, as well as other doctors, believe that
regulations do not go far enough, and that public safety is compromised due this. They
are concerned about the potential addictive qualities of opioid analgesics, in addition to
their side effects, and believe that a patient’s safety should be a matter of the highest
priority. They are also concerned about the illegal recreational use of these drugs, and the
possible consequences of making them more available.
Over the course of this paper I will show you why the pain management system is
flawed and demonstrate the cruelty of under-treating or not treating a person’s pain. I will
explain the causes of the problems with pain management, and refute the arguments
concerning addiction and abuse. Finally, I will guide the conclusion that the way we view
and treat pain is ineffective and inappropriate and should therefore be changed to better
It was easy to see the problems with pain management from the patient’s point of
view-- from where I was sitting when I was anxiously awaiting some pain relief.
Withholding treatment seemed an obvious issue, but for people who are not directly
suffering from this, the concept might be more difficult to grasp. Chronic pain alone
disables one in ten Americans, and over ninety billion dollars are lost by the United
States economy in the form of disability, medical costs, and paid absences
(“Chronic.org”). These numbers do not factor in pain due to other causes such as cancer
or arthritis, or the number of people affected by pain in other parts of the world. Of the
people in the world suffering from pain, eighty percent of them are either undertreated or
not treated at all (Chen). These numbers are unacceptable, and represent the poor
situation in which the pain management system currently resides.
A continuous problem for the pain management system is the understanding of
the mechanisms that produce pain. With chronic pain, the central nervous system
becomes sensitized, or continues to send pain signals despite what is happening at the
origin of the pain (Schneider 17). This makes finding the source of the pain and treating it
extremely difficult because even though the source may be healed, as long as the signals
are firing, the person is still in pain. This lack of knowledge is a complication in
diagnosing pain, which is its own challenge facing pain management.
Because pain is something that is felt by an individual, it ranges from difficult to
impossible to diagnose. Although there are qualitative tests to run through to determine a
person’s pain level, there are no definitive, quantitative ones like there are for other
medical problems. Also, patients who have been in pain for a while, adjust their lives and
their autonomic nervous system, so he or she does not exhibit traditional “pain behavior”
such as crying, wincing, or hyperventilating. A lack of these actions does not mean he or
she is not in pain, but that he or she has become accustomed to the pain so that it no
longer warrants these intense behaviors. The ability to diagnose is a doctor’s most useful
tool, yet pain evades that concrete knowledge. This makes many doctors cautious about
prescribing opioids like Percocet and Vicodin, despite the fact that they relieve pain
(Schneider 17). This is damaging to the patients because it causes the patients to suffer
unnecessarily. It is also harmful to the pain management system because it leads to a poor
patient-doctor dynamic, in which the doctor does not trust the patient and the patient
exaggerates his or her pain to convince the doctor to prescribe the medication he or she
should have prescribed in the first place (Parris). This becomes a vicious cycle with no
Another reason doctors are hesitant to prescribe pain medications is the rumors
surrounding them. According to Dr. Winston Parris, a Professor of Anesthesia and Chief
of Pain Programs at Duke University Medical Center, many doctors have a
misunderstanding as to the effects, both positive and negative, of opioid analgesics. Once
again, the primary issue seems to be a lack of knowledge on the doctors’ part. However,
it is not necessarily their fault, but the lack of research and knowledge of the field in
general. For example, there are no conclusive results on the long-term effects of opioids,
as shown by the equal number of studies concluding that they have dangerous long-term
effects and no long-term effects at all (Meier). Therefore, the debate over whether
continued use leads to addiction, tolerance, and abuse is circular without a definitive
answer. This ambiguity has many doctors reluctant to prescribe medicine that could
potentially be harmful to the patients, no matter how effective it is in the short-run. Even
without conclusive results, it can be observed that people who use it in the short-term and
with monitored dosages feel effective pain relief that is sometimes denied due to
Pain relief is also denied due to government agencies’ regulations, such as those
of the Food and Drug Administration, or FDA. These regulations restrict access to pain
medications on the basis of side effects, potential addiction, and recreational abuse,
though none of these reasons treat the actual patients fairly. As a pain sufferer, I
understand there are risks and side effects associated with opioid analgesics such as
drowsiness, weight gain, and in extreme cases cardiovascular complications (Payne 60).
In fact, even Bextra, an NSAID, was taken off the market in 2005 by the FDA because it
was shown that they had too great of risk of severe cardiovascular problems and deadly
skin disease, especially in the older patients it was being prescribed too (O’Connor).
However, there are just as many side effects associated with sleep medicine, baby aspirin,
and cancer treatments such as dependency, ulcers, nausea, and severe bone pain
respectively (“ACS”, “Baby”, & “Side”). The argument for the latter is that cancer is a
more serious issue because it leads to death, and in fact doctors are more willing to
prescribe opioids to cancer patients because their life span is already shortened
(Schneider 17). Nevertheless, pain affects more people and results in less overall
productivity than cancer, yet pain patients are subjected to more strict regulations and
testing (“Chronic.org”). This is cruel to the patients who are affected by a serious medical
problem that is not being taken seriously. These patients have a basic human right to
treatment, which is being denied by unnecessarily strict regulations.
Additionally, the FDA is concerned about the potential for addiction and the
recreational abuse of prescription medications (Woodcock 2105). Since the discovery of
Oxycontin, there has been an increase in the prescription drug abuse. In response to this,
they implemented stricter regulations regarding pain prescriptions (Schmidt 554). In
2001, the Drug Enforcement Agency (DEA) began investigating doctors, both physicians
and pharmacists to ward off accusations from Glen Fine, the inspector general of the
Department of Justice, that their organization was not effectively preventing illegal
prescription drug use. With the DEA and FDA targeting them, doctors became more
hesitant to prescribe opioids, even to those who needed them. Though, in general doctors
want to help patients, they are not willing to sacrifice their medical license to do so. This
is not beneficial to anyone. The patients do not receive the relief they require; the doctors
neither fulfill their potential nor abide by their oath to do no harm; and the government
agencies lose the public’s trust and support.
Although there is a problem with drug abuse, as noted by the 5.2 million people
who used prescription painkillers in a nonmedical way in 2007, it is wrong to punish
innocent patients in need of relief for their bad behavior (Clemmitt). This is clear because
despite the DEA’s attempt to tighten regulations on the prescription medication market in
2001, as of 2007, prescription medicine is still used for recreation by more than double
the number of people who use cocaine (McBride). If the tighter restrictions are not
preventing people from using prescription medicine recreationally as it was predicted
they would, then they should be revoked based on the inefficiency alone. This is not to
mention the negative effects these regulations have had on patients. As of December
2009, thirty two million Americans have experienced pain for over a year, and as of
March 2010, at least ten thousand pain patients are not being adequately treated because
of regulations (“Drugs” & Payne 60). This huge medical issue is not being treated
properly. If this affects this many people in our society, then the government whose job is
to help our society, should indeed help by loosening the restrictions on pain medications.
Now that the issue has been defined, and the causes have been made clear, I hope
it can be agreed that the current system of pain management is not working. There are too
many doctors under-treating or refusing to treat pain, and too many patients suffering
because of it. This is not a humane way to handle this. Although I agree that addiction
and abuse can be an issue, the pain of the innocent people is the bigger issue at hand, and
everyone should be viewed as innocent until proven guilty. Pain is not something that
shows up on a test or that a doctor can experience for the patient. Pain is one of the most
debilitating medical issues in the United States, so it is not a matter to be taken lightly
(McBride). Therefore, it is necessary for doctors to listen to their patients and trust that
they are telling them the truth. This would prevent patients from exaggerating to receive
Along with the doctors’ trust, government agencies such as the FDA need to trust
that the doctors are not going to prescribe the pain medication to anyone who walks
through their doors. Instead of establishing regulations preventing patients from feeling
relief, theses agencies should be instating regulations mandating everyone’s pain be
treated equally and taken seriously. Although the FDA should be far from promoting
overuse of the prescription pain, they should be advocating for the best quality of care
When it involves the issue of pain management, the general pain-feeling
community and the pain management government agencies are rarely on the same side.
Consequently, the debate over where to draw the line for regulations goes back and forth
much like an intense game of tug-of-war, with each team pulling with all its might to get
the flag on its side of the line. Ultimately, the flag belongs in the middle, or more towards
the patient care side, though currently it resides too far towards the regulations one. There
are many reasons as to why the flag belongs towards the patients. A person’s pain is of
the utmost importance because it interferes with daily functioning and activity, so to
ignore a person’s pain is cruel and unjust. Why would doctors be so cruel? Though the
potential dangers could be one reason, more likely is that they fear the very regulations
drug control organizations want to implement. While the government may be worried
about addiction and abuse, if good judgment is used and the patient is monitored, then
that should not be an issue. Lastly, although there is a prescription drug abuse problem in
the recreational field, there are too many people whose pain goes untreated or
undertreated for abuse to take the main priority. The pain community needs to come
together for further education about opioids and the mechanisms involved with pain
management. It needs to increase the number of patients who feel relief by decreasing
regulations and lightening the investigations on the prescribing physicians, or everyone
"ACS :: Symptoms and Side Effects." American Cancer Society :: Information and Resources for Cancer: Breast, Colon, Prostate, Lung and Other Forms. N.p.,
<http://www.cancer.org/docroot/MBC/MBC_2_Side_Effects.asp>.
"Baby Aspirin Oral Precautions and Side Effects." Prescription Drugs - Learn more at HealthSquare.com. N.p., n.d. Web. 10 May 2010.
<http://www.healthsquare.com/drugs/90853.htm>.
Chen, Te-Ping. "Denying Pain Medication: An International Law Violation? | Global
Health | Change.org." Global Health | Change.org. N.p., n.d. Web. 7 Mar.
<http://globalhealth.change.org/blog/view/denying_pain_medication_an_internat
"Chronicpain.org Chronic Pain Outreach." Chronicpain.org Chronic Pain Outreach.
N.p., n.d. Web. 11 May 2010. <http://www.chronicpain.org/>.
Clemmitt, M. (2009, October 9). “Medication Abuse”. CQ Researcher, 19, 837-860.
Retrieved April 1, 2010, from CQ Researcher Online,
http://library.cqpress.com/cqresearcher/cqresrre2009100900
"Drugs, Police & the Law." Drug Policy Alliance Network: Alternatives to Marijuana Prohibition and the Drug War. N.p., n.d. Web. 7 Mar. 2010.
McBride, Hugh. "Treating Chronic Pain and Addiction to Prescription Pain Killers -
Drug Dependency." Drug Rehab Centers. N.p., n.d. Web. 21 Apr. 2010.
<http://www.drug-rehab.com/chronic-pain-drug-addiction.htm>.
Meier, Barry. “The Delicate Balance of Pain and Addiction.” New York Times. Nov 2003.
O’Connor, Anahad. “Problems for Painkillers: The Clinical Science; Maybe Less Use for
Prescription Pens”. New York Times. Apr 2005. Pg. 4.
Parris, Winston. “Challenges and issues in Pain Management and Anesthesiology”.
Executive Healthcare Magazine. Issue 5. Accessed Mar 31 2010,
http://www.executivehm.com/article/Challenges-and-Issues-in-Pain-
Payne, January W. "Managing Your Pain, Minus Addiction." U.S. News & World Report
146, no. 11 (December 2009): 60-63. Academic Search Premier, EBSCOhost
Schmidt, Charles. "Experts Worry About Chilling Effect of Federal Regulations on
Treating Pain." Journal of the National Cancer Institute 97.8 (2005): 554-555.
Academic Search Premier. Web. 10 Mar. 2010.
Schneider, Jennifer. “Opioids, Pain Management, and Addiction”. Pain Practicioner.
"Side Effects of Sleep Drugs." U S Food and Drug Administration Home Page. N.p., n.d.
<http://www.fda.gov/forconsumers/consumerupdates/ucm107757.htm>.
Woodcock, Janet. "A Difficult Balance - Pain Management, Drug Safety, and the FDA."
New England Journal of Medicine 361.22 (2009): 2105-2107.
www.content.nejm.org. Web. 7 Mar. 2010.
Patentes Internacionales, cuando la ciencia muerde la mano que le da de comer. Por: Julio César Cázares Una situación mundialmente preocupante es la de las patentes, en específico me refiero al intento de Norteamérica de legislar la creación científica mundial y la consecuente explotación por parte de sus empresas hacia todo el mundo. (Con la salvedad que en México como siempre
LIST OF PUBLICATIONS REFERRED TO IN THE 23RD EDITION (2012 – 2013) OF THE BELGIUM – LUXEMBOURG VERSION OF THE SANFORDGUIDE TO ANTIMICROBIAL THERAPY TABLE 14D PARASITIC INFECTIONS: TREATMENT OF INFECTIONS DUE TO CESTODES Walker MD, Zunt JR. Neuroparasitic infections: cestodes, trematodes and protozoan García HH (Cysticercosis Working Group in Peru). Neurocysticercosis i